• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5
1
1
1

COUNTRY

1

CATEGORIES

  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

8
8
9
14

PUBLISHED

0
0
4
14

PRODUCT TYPE

7
5
2

Search "Helix BioPharma Corp.-Deals & Alliances Report" returned 14 results.

Helix BioPharma Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics (6th Edition)

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements...

December 2014
FROM

Gene Therapy Partnering Terms and Agreements (3rd Edition)

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

December 2014
FROM

Companion Diagnostics - Global Strategic Business Report

This report analyzes the worldwide markets for Companion Diagnostics in US$ Thousand The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

September 2011
FROM

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world,  in one complete volume. The report, The Worldwide Market for In Vitro...

July 2012
FROM

Medicated Skin Care Products - Global Business Strategic Report

This report analyzes the worldwide markets for Medicated Skin Care Products in US$ Million The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin...

May 2012
FROM

Theratechnologies Inc. (TH) - Financial and Strategic SWOT Analysis Review

Theratechnologies Inc. (TH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

May 2014
FROM

Molecular Diagnostics in Infectious Disease Testing

This report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics...

May 2015
FROM

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Non-Small Cell Lung Cancer - Pipeline Review, H2 2011', provides an overview of the Non-Small Cell Lung Cancer...

September 2011
FROM

North American Corporate Rating Scores By Industry Sector As Of March 5, 2015 May 15

Abstract Standard & Poor's Ratings Services is updating the rating component scores for its public corporate credit ratings in North America. This article follows a similar report published on Feb....

May 2015

S&P Extends Deadline For Comments On "Management And Governance" Credit Factors Apr 12

Abstract WASHINGTON D.C. (Standard & Poor's) April 12, 2012Standard & Poor's Ratings Services said today that as a result of significant interest by investors and rated companies, it will extend the...

April 2012

Standard & Poor's Extends Recovery Ratings To Unsecured Speculative-Grade Corporate Issues Mar 08

Abstract Standard & Poor's today has assigned recovery ratings to more than 1,800 unsecured loan and bond issues sold by nearly 900 speculative-grade rated corporate issuers in the U.S., Canada, and...

March 2008

Standard & Poor's Extends Recovery Ratings To Unsecured Speculative-Grade Corporate Issues Mar 08

Abstract Standard & Poor's today has assigned recovery ratings to more than 1,800 unsecured loan and bond issues sold by nearly 900 speculative-grade rated corporate issuers in the U.S., Canada, and...

March 2008

Recovery: Results Of Revisions To Recovery Rating Scale And Issue Level Rating Framework Jun 07

Abstract Standard & Poor's Ratings Services has reviewed its portfolio of almost 2,300 issue level and recovery ratings on speculative-grade secured loans and bonds, in connection with the May 30 release...

June 2007
Loading Indicator

Our Clients

Walgreen's Company Elanco Global Nu Skin Enterprises Kemin Industries, Inc. Suan Farma Inc. Metagenics, Inc.